01283nam a2200205Ia 4500 CTU_159308 210402s9999 xx 000 0 und d 614.599392 E84 Ethical considerations in biomedical HIV prevention trials Joint United Nations Programme on HIV/AIDS (UNAIDS) Geneva, Switzerland UNAIDS c2007 Well into the third decade of the HIV epidemic, there remains no effective HIV preventive vaccine, microbicide, product or drug to reduce the risk of HIV acquisition. As the numbers of those infected by HIV and dying from AIDS continue to increase, the need for such biomedical HIV preventive interventions becomes ever more urgent. Several such products are at various stages of development, including some currently in phase III efficacy trials. The successful development of effective HIV preventive interventions requires that many different candidates be studied simultaneously in different populations around the world. HIV infections,Clinical trials Moral and ethical aspects,Prevention,Moral ethical aspects Nhiễm HIV Trọng Hiếu Trung tâm Học liệu Trường Đại học Cần Thơ